• A de novo PAK1 likely pathogenic variant and a de novo terminal 1q microdeletion in a Chinese girl with global developmental delay, severe intellectual disability, and seizures
• A multiple myeloma-specific capture sequencing platform discovers novel translocations and frequent, risk-associated point mutations in IGLL5
• A New Case with Corpus Callosum Abnormalities, Microcephaly and Seizures Associated with a 2.3-Mb 1q43-q44 Deletion
• A Novel t(10;22) Translocation Harboring an IGL Gene Deletion in a CLL Patient Transforming to B-PLL with 1q Gain
• A rare case of 1q31.1-q32.1 deletion with congenital heart disease
• Aberrations of Chromosomes 1 and 16 in Breast Cancer: A Framework for Cooperation of Transcriptionally Dysregulated Genes
• Abstracts from the 3rd International Genomic Medicine Conference (3rd IGMC 2015) : Jeddah, Kingdom of Saudi Arabia. 30 November - 3 December 2015
• Acute Undifferentiated Leukemia With a Balanced t(5;10)(q35;p12) Resulting in Fusion of <em>HNRNPH1</em> With <em>MLLT10</em>
• Advanced forms of MPNs are accompanied by chromosomal abnormalities that lead to dysregulation of TP53
• Advances in the molecular characterization of multiple myeloma and mechanism of therapeutic resistance
• Adverse histology, homozygous loss of CDKN2A/B, and complex genomic alterations in locally advanced/metastatic renal mucinous tubular and spindle cell carcinoma
• AF1q Contributes to Adriamycin-Induced Podocyte Injury by Activating Wnt/β-Catenin Signaling
• An acquired high-risk chromosome instability phenotype in multiple myeloma: Jumping 1q Syndrome
• An uncommon t(9;11)(p24;q22) with monoallelic loss of <em>ATM</em> and <em>KMT2A</em> genes in a child with myelodysplastic syndrome/acute myeloid leukemia who evolved from Fanconi anemia
• Associations Between Amplification (1q) and Prior Cancer in a Real-World De Novo Myeloma Cohort
• Basal-like breast cancer: molecular profiles, clinical features and survival outcomes
• Biallelic deletion of 1p32 defines ultra-high-risk myeloma, but monoallelic del(1p32) remains a strong prognostic factor
• Cardiac angiosarcoma: histopathologic, immunohistochemical, and cytogenetic analysis of 10 cases
• Case Report: Candidate Genes Associated With Prenatal Ultrasound Anomalies in a Fetus With Prenatally Detected 1q23.3q31.2 Deletion
• Cell-free DNA copy number variations in plasma from colorectal cancer patients
• Characteristics and clinical significance of cytogenetic abnormalities in polycythemia vera
• Chromosome 1 instability in multiple myeloma: Aberrant gene expression, pathogenesis, and potential therapeutic target
• Chromosome 1q Terminal Deletion and Congenital Glaucoma: A Case Report
• Chromosome 1q31.2q32.1 deletion in an adult male with intellectual disability, dysmorphic features and obesity
• Chromosome aberrations [dup(1q)] in endometrial cancer: Gene analysis of 54 surgical specimens in Turkey
• Chromosome arm 1q gain is an adverse prognostic factor in localized and diffuse leptomeningeal glioneuronal tumors with BRAF gene fusion and 1p deletion
• Circulating Tumor DNA as a Biomarker in Patients With Stage III and IV Wilms Tumor: Analysis From a Children's Oncology Group Trial, AREN0533
• Clinical features and prognostic factors of advanced myelodysplastic syndromes in children
• Conventional Cytogenetics and Interphase Fluorescence In Situ Hybridization Results in Multiple Myeloma: A Turkey Laboratory Analysis of 381 Cases
• Copy Number Alterations Associated with Acute Lymphoblastic Leukemia in Mexican Children. A report from The Mexican Inter-Institutional Group for the identification of the causes of childhood leukemia
• Copy number profiling of adult relapsed B-cell precursor acute lymphoblastic leukemia reveals potential leukemia progression mechanisms
• Copy number variation in triple negative breast cancer samples associated with lymph node metastasis
• Cytogenetic Abnormalities in Multiple Myeloma: Incidence, prognostic significance and geographic heterogeneity in Indian and western population
• Cytogenetic Abnormalities in Multiple Myeloma: Incidence, Prognostic Significance, and Geographic Heterogeneity in Indian and Western Populations
• Cytogenetic and FISH analysis of 93 multiple myeloma Moroccan patients
• Cytogenomic characterization of 1q43q44 deletion associated with 4q32.1q35.2 duplication and phenotype correlation
• Deciphering the chronology of copy number alterations in Multiple Myeloma
• Differences in Genomic Profiles and Outcomes Between Thoracic and Adrenal Neuroblastoma
• Distal chromosome 1q aberrations and initial response to ibrutinib in central nervous system relapsed mantle cell lymphoma
• Distribution of segmental chromosomal alterations in neuroblastoma
• Effect of 1q21 amplification on bortezomib therapeutic response and prognosis of newly diagnosed multiple myeloma patients
• Functional Impact of Genomic Complexity on the Transcriptome of Multiple Myeloma
• Generation of chromosome 1p/19q co-deletion by CRISPR/Cas9-guided genomic editing
• Genetic analysis of a case with Pierre-Robin sequence due to partial 1q trisomy and partial 4q monosomy
• Genetic analysis of a fetus with partial 1q monosomy and partial 17q trisomy
• Genetic and epigenetic alterations in meningiomas
• Genome-wide screening for genomic aberrations in Kazakh patients with esophageal squamous cell cancer by comparative genomic hybridization
• Genomic and Metabolic Hallmarks of SDH- and FH-deficient Renal Cell Carcinomas
• Genomic and transcriptomic characterization of desmoplastic small round cell tumors
• Genomic characterisation of multiple myeloma: study of a Portuguese cohort
• Genomic profile of columnar cell variant of papillary thyroid carcinoma
• Identification and monitoring of Copy Number Variants (CNV) in monoclonal gammopathy
• Impact of Aneuploidy and Chromosome 9p Loss on Tumor Immune Microenvironment and Immune Checkpoint Inhibitor Efficacy in NSCLC
• Impact of bortezomib-based versus lenalidomide maintenance therapy on outcomes of patients with high-risk multiple myeloma
• Impact of cytogenetic abnormalities on the risk of disease progression in solitary bone plasmacytomas
• Impact of Disseminated Neuroblastoma Cells on the Identification of the Relapse-Seeding Clone
• Inherited Deletion of 1q, Hyperparathyroidism and Signs of Y-chromosomal Influence in a Patient with Turner Syndrome
• Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma
• Integrative analysis reveals driver long non-coding RNAs in osteosarcoma
• Language impairment with a microduplication in 1q42.3q43
• Low-Coverage Sequencing of Urine Sediment DNA for Detection of Copy Number Aberrations in Bladder Cancer
• Mesonephric-like Adenocarcinoma of the Uterine Corpus: Genomic and Immunohistochemical Profiling with Comprehensive Clinicopathological Analysis of 17 Consecutive Cases from a Single Institution
• Minor clone of del(17p) provides a reservoir for relapse in multiple myeloma
• Molecular cytogenetic characterization of 1q42.3q44 deletion and 8q24.3 duplication in a fetus with single umbilical artery and ventricular septal defects
• Molecular landscapes of longitudinal NF2/22q and non-NF2/22q meningiomas show different life histories
• Molecular subtyping of ependymoma and prognostic impact of Ki-67
• Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features
• Multiomic mapping of acquired chromosome 1 copy number and structural variants to identify therapeutic vulnerabilities in multiple myeloma
• Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
• Myxedema Coma Secondary to Central Hypothyroidism: A Rare but Real Cause of Altered Mental Status in Pediatrics
• Nine year old boy with chromosome 1q23.3-q25.1 deletion
• Novel Cytogenetic Findings in a Case of Mixed Phenotype Acute Leukemia within the Context of a Complex Karyotype
• Novel recurrent chromosomal aberrations detected in clonal plasma cells of light chain amyloidosis patients show potential adverse prognostic effect: first results from a genome-wide copy number array analysis
• Nucleic acid based risk assessment and staging for clinical practice in multiple myeloma
• Observation on frequency &amp; clinico-pathological significance of various cytogenetic risk groups in multiple myeloma: an experience from India
• Opposite chromosome constitutions due to a familial translocation t(1;21)(q43;q22) in 2 cousins with development delay and congenital anomalies: A case report
• Optical Genome Mapping Reveals the Complex Genetic Landscape of Myeloma
• Outcome of Multiple Myeloma with Chromosome 1q Gain and 1p Deletion after Autologous Hematopoietic Stem Cell Transplantation: Propensity Score Matched Analysis
• p53-NEIL1 co-abnormalities induce genomic instability and promote synthetic lethality with Chk1 inhibition in multiple myeloma having concomitant 17p13(del) and 1q21(gain)
• Pan cancer patterns of allelic imbalance from chromosomal alterations in 33 tumor types
• Plasmablastic myeloma in Taiwan frequently presents with extramedullary and extranodal mass mimicking plasmablastic lymphoma
• Polysomy is associated with poor outcome in 1p/19q codeleted oligodendroglial tumors
• Prenatal diagnosis and molecular cytogenetic characterization of a chromosome 1q42.3-q44 deletion in a fetus associated with ventriculomegaly on prenatal ultrasound
• Prenatal diagnosis of a terminal chromosome 1 (q42-q44) deletion: original case report and review of the literature
• Prognostic Value and Efficacy Evaluation of Novel Drugs for Multiple Myeloma Patients with 1q21 Amplification (Amp1q21) Only: A Systematic Review of Randomized Controlled Trials
• Quantitative PCR: an alternative approach to detect common copy number alterations in multiple myeloma
• Quantitative phenotypic and network analysis of 1q44 microdeletion for microcephaly
• RanGAP1 maintains chromosome stability in limb bud mesenchymal cells during bone development
• Recurrent Somatic Chromosomal Abnormalities in Relapsed Extraocular Retinoblastoma
• Remodeling and destabilization of chromosome 1 pericentromeric heterochromatin by SSX proteins
• Somatic genomic imbalances in 'tumour-free' surgical margins of oral cancer
• Stable transmission of complex chromosomal rearrangements involving chromosome 1q derived from constitutional chromoanagenesis
• TERT promoter mutations and chromosome 8p loss are characteristic of nonalcoholic fatty liver disease-related hepatocellular carcinoma
• The genetic landscape of 5T models for multiple myeloma
• The multiple myelomas - current concepts in cytogenetic classification and therapy
• The spectrum of somatic mutations in monoclonal gammopathy of undetermined significance indicates a less complex genomic landscape than that in multiple myeloma
• Whole Exome Sequencing of Biliary Tubulopapillary Neoplasms Reveals Common Mutations in Chromatin Remodeling Genes
• Whole genome sequencing of apparently mutation-negative MEN1 patients
• Whole-exome sequencing reveals mutational profiles of anorectal and gynecological melanoma
• Whole-Genome Comparative Copy Number Alteration Profiling between Malignant Pleural Mesothelioma and Asbestos-Induced Chronic Pleuritis